Personalized‐Context‐Aware Age Gap: A New Multi‐Omics Measurement Based on Age‐Enhanced Model <scp>AOE</scp> ‐Net for Aging Acceleration and Chronic Disease Risk Prediction

ABSTRACT Aging is a global issue that affects human health and increases disease risk. The traditional concept of the “age gap (AG),” defined as the difference between estimated biological age and an individual's chronological age, has been used for self‐monitoring the risk of age‐related diseases. However, the current AG does not account for the stratified aging patterns across different stages of chronological age, which may lead to biased or paradoxical interpretations of aging acceleration. To address these limitations, we propose Personalized‐context‐Aware Age Gap (PAAG), a robust metric to estimate aging acceleration, based on our new pre‐training model AOE‐Net (Age Order Enhanced Network). AOE‐Net employs age‐order enhanced contrastive learning on multi‐omics data from healthy populations to learn latent representations that accurately reconstruct aging trajectories by capturing biological deviation rather than technical deviation in omics data. We demonstrate that PAAG, generated via fine‐tuning AOE‐Net, significantly outperforms AG of conventional first‐ and second‐generation aging clocks in predicting clinical outcomes. This superior predictive power was validated across diverse age‐related diseases and phenotypes: pan‐cancer (overall survival), subclinical atherosclerosis (PESA score), and osteoporosis (bone mineral density). Crucially, PAAG serves as a context‐aware metric that may improve the clinical outcome prediction of existing aging clocks. Furthermore, interpretive analysis of PAAG's molecular drivers revealed a strong functional enrichment for immune‐response pathways, providing a shared mechanistic link between accelerated aging and disease. Collectively, PAAG could serve as a stable indicator of aging acceleration for clinically assessing age‐related diseases, and AOE‐Net provides an effective pre‐training model for aging study and PAAG evaluation.

Authors

Institutions

Publication Details

Journal
Aging Cell
Published
2026-05-28
DOI
https://doi.org/10.1111/acel.70552
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Personalized‐Context‐Aware Age Gap: A New Multi‐Omics Measurement Based on Age‐Enhanced Model AOE ‐Net for Aging Acceleration and Chronic Disease Risk Prediction

H Wang, Jiarui Cui, Feng‐ao Wang, Ruikun He et al.
Aging Cell
Epigenetics and DNA Methylation
article

Personalized‐Context‐Aware Age Gap: A New Multi‐Omics Measurement Based on Age‐Enhanced Model AOE ‐Net for Aging Acceleration and Chronic Disease Risk Prediction

H Wang, Jiarui Cui, Feng‐ao Wang, Ruikun He, Jiangxun Ji, Yue Wang, Y LI, Erle Deng, Yule Yu, Chunchun Yuan, Tao Zeng, Dezhi Tang
article en

Abstract

ABSTRACT Aging is a global issue that affects human health and increases disease risk. The traditional concept of the “age gap (AG),” defined as the difference between estimated biological age and an individual's chronological age, has been used for self‐monitoring the risk of age‐related diseases. However, the current AG does not account for the stratified aging patterns across different stages of chronological age, which may lead to biased or paradoxical interpretations of aging acceleration. To address these limitations, we propose Personalized‐context‐Aware Age Gap (PAAG), a robust metric to estimate aging acceleration, based on our new pre‐training model AOE‐Net (Age Order Enhanced Network). AOE‐Net employs age‐order enhanced contrastive learning on multi‐omics data from healthy populations to learn latent representations that accurately reconstruct aging trajectories by capturing biological deviation rather than technical deviation in omics data. We demonstrate that PAAG, generated via fine‐tuning AOE‐Net, significantly outperforms AG of conventional first‐ and second‐generation aging clocks in predicting clinical outcomes. This superior predictive power was validated across diverse age‐related diseases and phenotypes: pan‐cancer (overall survival), subclinical atherosclerosis (PESA score), and osteoporosis (bone mineral density). Crucially, PAAG serves as a context‐aware metric that may improve the clinical outcome prediction of existing aging clocks. Furthermore, interpretive analysis of PAAG's molecular drivers revealed a strong functional enrichment for immune‐response pathways, providing a shared mechanistic link between accelerated aging and disease. Collectively, PAAG could serve as a stable indicator of aging acceleration for clinically assessing age‐related diseases, and AOE‐Net provides an effective pre‐training model for aging study and PAAG evaluation.

Aging CellVol. 25(6)
Ministry of Education of the People's Republic of China (CN), Guangxi University (CN), Shanghai University of Traditional Chinese Medicine (CN), Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN), Guangzhou Regenerative Medicine and Health Guangdong Laboratory (CN), Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality (CN), Guangzhou Institute of Dermatology (CN), University of Chinese Academy of Sciences (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 8%
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.